Live feed09:00:00·4mPRReleasevia QuantisnowGenprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat CancerByQuantisnow·Wall Street's wire, on your screen.GNPX· Genprex Inc.Health Care
